Physician and Patient Safety Act
Summary
The Physician and Patient Safety Act (HR3413) is an early-stage bill that mandates due process procedures for physicians before hospitals can restrict staff privileges. The bill contains no direct funding, is referred to committee with only 6 cosponsors, and carries negligible near-term market impact for the healthcare sector.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR3413 is pure regulatory mandate with zero funding — no direct money trail for investors to follow.
- 2.Bill has not moved past committee referral in 11 months; companion bill also stalled in Senate.
- 3.If enacted, hospital operators ($HCA, $UHS) face minor administrative cost friction, but impact is immaterial to earnings.
- 4.No listed physician or healthcare services company has material revenue exposure to this procedural change.
Market Implications
No actionable market implications. This bill does not alter reimbursement rates, coverage mandates, drug pricing, or any revenue driver for publicly traded healthcare companies. Hospital operators $HCA and $UHS would face negligible incremental compliance costs. Investors should monitor for unexpected movement (committee markup, inclusion in must-pass health legislation) but current baseline expectation is that HR3413 dies in committee.
Full Analysis
-
What happened: HR3413 was introduced in the House on May 14, 2025 by Rep. Ruiz (D-CA) and referred to the House Committee on Energy and Commerce. The bill has 6 cosponsors and an identical companion bill (S1767) in the Senate. As of today (April 30, 2026), the bill remains in committee with no further action — it is stalled in early stage.
-
The money trail: There is zero funding authorization or appropriation in this bill. It is a pure regulatory mandate — it instructs HHS to issue regulations requiring hospitals to provide fair hearings and appellate review before terminating or restricting physician staff privileges. No federal dollars flow. No tax credits, grants, or procurement programs are created.
-
Structural winners and losers: This is not a market-moving bill. Hospitals ($HCA, $UHS) face modest operational friction from additional administrative and legal procedures, but the cost is immaterial relative to their revenue bases (HCA's 2025 revenue ~$70B; UHS ~$16B). Physician staffing companies ($AMN, $CHG Healthcare private) could see minor benefits if the due-process protections make hospital employment less desirable, but this is speculative and not grounded in bill text. No clear winners.
-
Timeline: The bill requires HHS to issue final regulations within 18 months of enactment. However, the bill has not advanced out of committee in nearly a year. Without substantial committee leadership sponsorship or a broader legislative vehicle, passage in this Congress is unlikely.
Intelligence Surface
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
Some confirming evidence found across public data sources
What the bill does
Regulatory mandate requiring hospitals to provide fair hearing and appellate review before restricting physician staff privileges
Who must act
Hospitals that have granted medical staff privileges to physicians, including HCA Healthcare facilities
What happens
Operational cost increase from establishing and administering hearing/appellate review processes; potential delay in removing underperforming physicians from staff
Stock impact
HCA operates ~180 hospitals and ~2,300 care sites; each facility must now institute due-process hearings before restricting physician privileges, adding legal and administrative overhead. No direct revenue impact, but increased operational friction.
What the bill does
Regulatory mandate requiring hospitals to provide fair hearing and appellate review before restricting physician staff privileges
Who must act
Hospitals that have granted medical staff privileges to physicians, including Universal Health Services facilities
What happens
Operational cost increase from establishing and administering hearing/appellate review processes; potential delay in removing underperforming physicians from staff
Stock impact
UHS operates ~330 acute care hospitals and behavioral health facilities; each must implement due-process procedures before restricting privileges. Increased legal and administrative costs, no revenue impact.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
CAPEX & D SQUARE, A JOINT VENTURE LLC: $23.2M Department of Veterans Affairs Contract
Veterans’ Assuring Critical Care Expansions to Support Servicemembers (ACCESS) Act of 2025
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Debt Collection Practices (Regulation F); Deceptive and Unfair Collection of Medical Debt".
SPREZZATURA MANAGEMENT CONSULTING, LLC: $23.2M Department of Veterans Affairs Contract
Nurse Staffing Standards for Hospital Patient Safety and Quality Care Act of 2025
To amend title XVIII of the Social Security Act to prevent hospitals or skilled nursing facilities that are owned by certain firms from participating in the Medicare program.
CHOICE for Veterans Act of 2025
Hospital Transparency Compliance Enforcement Act
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Accelerating Access To Veterans' Benefits And Employment Opportunities
This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.
Delivering Gold Standard Childhood Vaccine Recommendations for Americans
This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.
Continuing to Protect the Meaning and Value of American Citizenship
This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →